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Purified rat CD4 T cells were activated in vitro, by the polyclonal mitogen Concanavalin A
(Con A) or by mixed lymphocyte reaction (MLR), in the presence or absence of the
glucocorticoid dexamethasone (DEX). They were then expanded in IL-2 and subsequently
restimulated, this time in the absence of the hormone. The results indicate that the exposure of
the cells to DEX in the primary stimulation changed the cytokine synthesis induced by the
secondary stimulation. IL-4 production was increased by the pretreatment whereas synthesis of
IFN-y was diminished. Addition of DEX in the second activation suppressed all cytokine
production. In brief, the transient presence of glucocorticoids in the culture induces a change in
the pattern of cytokine production but the continuous presence causes inhibition of cytokine
synthesis. Further studies in which IL-4 was used together with DEX showed that the cytokine
potentiated the effect of the hormone.
The data here presented suggest that glucocorticoids and the neuroendocrine system may be
expected to have long-term immunological effects as well as short-lived immunosuppressive
ones. High concentration of glucocorticoids suppress cytokine production but when steroids
return to basal levels the immune response is directed in a way that favors Th2-type reactions.
Possible implications regarding the immune response to pathogens and autoantigens are
discussed.
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INTRODUCTION
Understanding the influence of glucocorticoids on the
immune system is important for two reasons: first,
corticosteroids are used as immunosuppressive and
anti-inflammatory agents in organ transplantation and
in the treatment of many autoimmune and inflamma-
tory diseases. Second, it is not commonly recognised
that, in addition to their pharmacological actions,
these steroids are natural hormones that play an
essential physiological role in the regulation of the
immune system. Release of endogenous glucocor-
ticoids protects us against our own defense mecha-
nisms by preventing an excessive immunological
reaction (Munck et al., 1984). During the course of an
immune response corticoid secretion from the adrenal
glands is increased and this mechanism limits the
magnitude of the inflammatory reaction to an immu-
nogenic stimulus (Besedovsky et al., 1975). Follow-
ing activation of the immune system several soluble
factors that activate the neuroendocrine system are
released (Besedovsky et al,., 1981). Partial failures in
this interaction between the immune and neuroendo-
crine systems contribute to the pathogenesis of certain
autoimmune and inflammatory experimental diseases
like thyroiditis, arthritis and experimental allergic
encephalomyelitis (EAE) (Kroemer et al., 1988;
MacPhee et al., 1989; Sternberg et al., 1989; Mason et
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al., 1990). There are also evidences that patients with
rheumatoid arthritis show a defective regulation of
corticosteroids production (Chikanza et al., 1992).
Our interest in the role of corticosteroids in the
regulation of the immune response originated from
the study of EAE in Lewis rats. EAE is an animal
model of autoimmune disease, similar to multiple
sclerosis, that can be induced in the appropriate
animal strains after immunization with myelin basic
protein (MBP) in complete Freund’s adjuvant. EAE in
Lewis rats is a monophasic disease characterized by a
single episode of paralysis, caused by the action of
CD4 T lymphocytes on the nervous system, followed
by spontaneous recovery. Animals that have
recovered are refractory to attempts to induce further
episodes of disease (Zamvil and Steinman, 1990). The
mechanisms responsible for the spontaneous recovery
and the maintenance of the refractory state, although
object of intense research, are not completely under-
stood. One mechanism that controls the course of
EAE is neuroendocrine-mediated immunoregulation.
It has been shown that endogenously produced
corticosterone plays an essential role in the recovery
of rats from EAE: Unlike normal rats, adrenalecto-
mized animals do not recover spontaneously but
instead develop a progressive paralysis with a fatal
consequence.
If these animals are administered corticosterone,
they recover and become refractory to the develop-
ment of new episodes of disease (Levine et al., 1980;
MacPhee et al., 1989). The spontaneous recovery of
rats from EAE probably occurs because cortico-
steroids, which are found at high levels in the sera of
paralyzed animals, acutely depress the autoimmune
response through their immunosuppressive effects.
However, animals that have recovered from disease
have normal serum steroid levels indicating that
corticosteroids are not directly responsible for the
maintenance of the refractory phase of the disease.
These findings suggest that, in addition to their acute
immunosuppressive actions, corticosteroids may dis-
play a more subtle and long-lasting effect on the
immune response. As EAE elicited by MBP in the
Lewis rat is a cell-mediated disease involving T cells
that produce IL-2 and IFN-y (Sedgwick et al., 1989),
the refractory phase of EAE could in principle be
explained if it could be shown that corticosteroids
inhibit proinflammatory cytokine production and
induce the production of cytokines that inhibit cell-
mediated immune responses (Mason, 1991).
Corticosteroids inhibit the production of many
interleukins during T-cell activation (Gillis et al.,
1979; Snyder and Unanue, 1982; Arya et al., 1984;
Beutler et al., 1986; Waage et al., 1990; Wu et al.,
1991). The question we want to answer in the
experiments here described is whether in situations
where corticosteroid concentration is increased, thera-
peutically or physiologically, there are any long-term
effects produced by the hormone. To elucidate the
answer, we have used a similar approach to that
employed by others to study the effects of the
presence of some cytokines on the development of the
immune response (Swain et al., 1988). Cells were
activated in the presence of the glucocorticoid
analogue dexamethasone (DEX) and cytokine pro-
duction was examined after a second round of in vitro
stimulation in the absence of the hormone. This
experimental design mimics the in vivo situation in
EAE, and also during an immune response to a
foreign antigen, where the increases in blood corticos-
teroid levels are transient. We have found that the
primary stimulation ofCD4 T cells in the presence of
DEX induces on a secondary activation the produc-
tion of more IL-4 protein and the synthesis of less
IFN-y. We observe this effect on cells activated by
Con A and in the MLR.
RESULTS
The Presence of Dexamethasone During Primary
Con A Activation Increases IL-4 mRNA in CD4
T Cells After Secondary Stimulation in the
Absence of the Hormone
Although glucocorticoids inhibited IL-4 production in
a primary activation (Wu et al., 1991; Byron et al.,
1992; Ramrez et al., 1996), a different result was
obtained when DEX-treated cells were activated a
second time in the absence of the hormone (RamfrezINDUCTION OF A TH2 RESPONSE BY GLUCOCORTICOIDS 235
et al., 1996). This protocol, shown in Figure 1, was
designed to examine whether corticosteroid primes
the cells to produce a particular cytokine response on
restimulation and also to mimic to a degree the in vivo
situation in EAE, where only a transient increase in
blood corticosterone levels occurs.
Measurements were made of the levels of IL-4
mRNA from cells cultured in the presence or absence
of DEX by RT-PCR analysis. Figure 2 shows that
CD4 T cells cultured with the steroid during the
primary activation and expansion periods (lanes 7-9)
expressed approximately tenfold higher levels of IL-4
mRNA after secondary activation than cells cultured
in the absence of DEX (lanes 1-3). In a previous
paper, it was shown that mRNA for IL-10 and IL-13
showed the same temporal variation as that for IL-4
(Ramirez et al., 1996). Similar results to the one
shown in Figure 2 are obtained when cells are in the
presence of the glucocorticoid only during the
expansion phase (data not shown): It is evident that to
induce an increase in IL-4 mRNA, it is not necessary
to include the hormone in the culture from the
primary activation to the expansion phase.
To exclude the possibility that the mechanism of
IL-4 mRNA induction shown in Figure 2 is due to
carry over of the hormone from the expansion phase
into the second activation, DEX was added intention-
ally in the secondary activation. In this condition, a
strong reduction in the amount of IL-4 mRNA was
observed in DEX-treated cells (lanes 10-12) and
untreated cultures (lanes 4-6). IFN-y production was
also strongly inhibited when DEX was added in the
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FIGURE Experimental design to analyze long-lasting effects of dexamethasone on cytokine production. T-cell activation was performed
by Con A or MLR. To analyze DEX effects on Con A-activated cells the following protocol was adopted: CD4 T cells (106/ml) were
cultured with accessory cells (106/ml) and incubated with 5/g/ml Con A in the presence of different combinations of DEX (10 M) and
rIL-4 (500 U/ml) for 3 days (primary activation phase). The cells were washed and cultured (105/ml) for 4 days in the presence of rIL-2 (50
U/ml), some cultures were supplemented with different combinations ofDEX (10
-8 M) and rIL-4 (500 U/ml) (expansion phase). Cells were
recovered and restimulated with 5 /xg/ml of Con A in the presence of accessory cells and in the absence of DEX and rIL-4 (secondary
activation phase). After 24 hr of the secondary activation, RNA was extracted from the different cell cultures and supernatants were removed
for cytokine analysis. To analyze DEX effects on MLR, the protocol was identical to the one described before but cell densities were 2.5
X 106 responder cells/ml and 2.5 106 stimulator cells/ml on the primary activation. During the expansion phase, cells were cultured at
106 cells/ml. In the secondary activation, stimulator cells densities were 2.5 106 cells/ml, but responder cell densities was reduced to 106
cells/ml. Supernatants were removed at 48 hr of culture.236 F. RAM[REZ
secondary activation (data not shown), indicating that
the presence of glucocorticoids in a primary or
secondary activation inhibits the production of IL-4
and IFN- y.
The Effects of Dexamethasone on IL-4 mRNA
Levels are Reproduced at the Level of Cytokine
Secretion
In the previous experiment (Figure 2), IL-4 produc-
tion was analyzed at the level ofRNA due to the lack
of an assay for rat IL-4 protein. An anti-rat IL-4 mAb,
which blocks the biological activity of rat IL-4, was
obtained recently in our laboratory. It is now possible
to quantitate the IL-4 protein in different supernatants
testing their capacity to induce the upregulation of
MHC class II expression on purified B cells. To assess
the specificity of the bioassay, the anti-IL-4 mAb OX-
81 is added to the cultures (Ramfrez et al., 1996). The
levels of IL-4 protein in the supernatants from DEX-
treated CD4 T-cell cultures were assayed and this is
shown in Figure 3. Cells treated with DEX during the
primary activation and expansion stages produce
more IL-4 after secondary activation than control
cultures not treated with DEX (undetectable levels).
In this experiment, IL-4-treated cells were included as
a positive control for the assay, because it is known
that IL-4 upregulates its own production (Swain et al.,
1990). IL-4- and DEX-treated cells were also
included to analyze the effect of the addition of both
reagents together in the synthesis of IL-4. As
expected, cells activated and expanded in the presence
of rIL-4 alone or rIL-4 and DEX together produced
higher amounts of IL-4 than the control cultures or
DEX-treated cells. Although not shown, cells acti-
vated and expanded in the presence of rIL-4 or rIL-4
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FIGURE 2 Dexamethasone increases IL-4 mRNA levels in Con A-activated CD4 T cells after secondary activation. Purified rat CD4 T
cells from LN were activated (106/ml) with Con A (5 #g/ml) in the presence of accessory cells. After a 3-day activation period, the cells
were maintained in rIL-2 for 4 days. Cells were cultured with different combinations of DEX and rIL-4 during the primary activation and
expansion periods as described in Materials and Methods (see Fig. 1). Cells were reactivated with Con A in the presence of accessory cells.
After a 24-hr activation period, total cellular RNA was extracted and analysis of IL-4 and/3-actin mRNA levels were performed by the RT-
PCR technique as described in Materials and Methods. Three tenfold dilutions from each cDNA sample were amplified by PCR (neat, 1/10,
and 1/100). In the gel electrophoresis, lanes 1-3 represent amplified products from increasing dilutions ofcDNA from control treatment cells,
lanes 4-6 amplified products from cDNA from control treatment cells treated during the secondary activation with 10 M DEX, lanes 7-9
amplified products from cDNA from cells cultured during the primary activation and expansion phases in the presence of 10-8 M DEX, and
lanes 10-12 amplified products from cDNA from cells cultured during the primary activation, expansion phases and secondary activation in
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FIGURE 3 Dexamethasone increases IL-4 protein synthesis in Con A-restimulated CD4 lymphocytes. Purified rat CD4 lymphocytes
from LNC and thoracic duct were activated as described for Fig. 2 and after 24 hr of the secondary activation supernatants were removed
for analysis of IL-4 protein by the class II induction assay on B cells, as described in Materials and Methods. The results are depicted as
units of IL-4/ml of supernatant calculated by comparison with a rIL-4 standard curve.
and DEX together showed higher IL-4 mRNA levels
than DEX-treated cells.
CD4 T Cells Activated by Con A in the
Presence of Dexamethasone in the Primary
Activation Yield Less Thl Cytokines on
Secondary Stimulation Than Do Controls
Following the observation that prior activation of
CD4 T cells in the presence of DEX lead to an
increase in Th2 cytokine synthesis after secondary
activation (Figure 2; Ramirez et al., 1996), an analysis
was made of the production of Thl cytokines.
Experiments were also carried out to examine the
effects on Thl cytokine production of adding rIL-4 in
the primary activation and expansion phases either
alone or in conjunction with DEX. The results are
shown in Figure 3 (only IFN-y production is depicted
from a particular experiment) and Figure 4 (from
several experiments including IFN-% TNF and IL-2
analysis). Cells cultured in the presence of DEX
during the primary activation and expansion stages
showed reduced IFN-y production on subsequent
reactivation in the absence of the hormone (31% of
control levels). When rIL-4 alone was included in the
cultures, CD4 T cells synthesized similar levels of
IFN-y after secondary stimulation to cells activated
by Con A alone. However, if the cells were cultured
in the presence of rIL-4 and DEX, there was a striking
inhibition of the production of this cytokine (85%
inhibition) after secondary stimulation. The lack of
inhibition of IFN-y production by rIL-4 observed in
these experiments is in contrast to data published by
others (Swain et al., 1990). This point will be
discussed further later in this paper.
For TNF production, it was observed that the
presence of DEX in both the primary activation and
IL-2 expansion phases decreased the production of
this cytokine (66% inhibition) (Figure 4). In contrast
to the effects observed on IFN-y production, the
addition of rIL-4 to the cultures during the primary
activation and expansion phases showed an inhibitory
effect on TNF synthesis (71% inhibition), and this
effect was stronger when the rIL-4 was supplemented
with DEX (86% inhibition).
IL-2 levels were also determined for the same
cultures as those assayed for IFN-y and TNF (Figure
4). DEX treatment did not produce a marked inhibi-
tory effect on IL-2 synthesis in the second stimulation
(24% inhibition). The presence of rIL-4 during the
primary activation resulted in inhibition of IL-2
production on secondary stimulation (63% inhibition)238 E RAM[REZ
and this effect was enhanced in the presence of DEX
(98% inhibition).
The Presence of Dexamethasone During Primary
T-Cell Activation in a MLR Increases IL-4
Production in CD4 T Cells After Secondary
Stimulation in the Absence of the Hormone
In the previous experiments, cytokine production was
analyzed after Con A activation. It was important to
show that the effect of glucocorticoid on cytokine
production is independent of the mechanism of T-cell
activation. To address this point, analyses of cytokine
production were made after MLR activation follow-
ing the same protocol employed for Con A activation
(Figure 1). Figure 5 shows that DEX-treated cells
produce more IL-4 than untreated cells (no IL-4 was
detected), but IL-4 is a better inducer of IL-4 than
DEX. DEX and IL-4 added separately or together
during the primary MLR reduce strikingly IFN-T
production by CD4 T cells on secondary MLR
activation (Figure 5). The result obtained treating
MLR-activated cells with IL-4 is different to the one
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FIGURE 4 The effects of dexamethasone and IL-4 on IFN-y, IL-2, and TNF synthesis by restimulated CD4 T cells. Purified rat CD4
lymphocytes from LNC and thoracic duct were taken through the three-step activation process depicted in Fig. 1. In the last stage, cells were
reactivated with Con A in the presence of accessory cells and the levels of IFN-T, TNF, and IL-2 after 24 hr of the secondary activation
were determined as described in Materials and Methods. Results from at least four different experiments are depicted as mean % S.D. of
the relative cytokine production by the cells in different culture conditions compared to the control incubation (considered 100%; dashed
line). Supernatants represented were as follows: DEX (cells activated and expanded in the presence of DEX); IL-4 (cells activated and
expanded in the presence of rIL-4); and IL-4+DEX (cultures maintained during the activation and expansion phases with rIL-4 and
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FIGURE 5 The effects of dexamethasone and IL-4 on IFN-y and IL-4 synthesis by CD4 T cells stimulated by MLR. PurifiedDA rat CD4
lymphocytes from LNC were stimulated with irradiated Lewis splenocytes in the presence ofDEX (10-8M), IL-4 (500 U/ml), both reagents
together, or medium alone. After a 3-day stimulation period, the cells were washed and cultured for 4 days in the presence of IL-2; some
cultures were supplemented with different combinations ofDEX and IL-4. The cells were recovered and restimulated with irradiated Lewis
splenocytes. After 48 hr of the secondary activation, supernatants were removed and the levels of IFN-y and IL-4 were determined.




In the present study, we show that the corticosteroid-
analogue DEX induces an increase in IL-4 production
and a decrease in IFN-y and TNF synthesis on
reactivated CD4 T cells that had been previously
cultured for week in the presence of the hormone.
IL-4 and DEX appeared to act synergistically in that
together they induced a high level of production of
IL-4 and very low levels of IL-2, TNF, and IFN-T.
This is the characteristic pattern of cytokine produc-
tion by mouse Th2 lines (Mosmann and Coffman,
1989). Two different activation protocols, Con A and
MLR, were employed with similar results. The
different culture conditions, although showing differ-
ent pattern of cytokine production, resulted in essen-
tially equally vigorous proliferation in the secondary
stimulation (Ramirez et al., 1996). Although not
shown, analysis of the production of other Th2
cytokines by reactivated CD4 T cells have been
performed: IL-6 production (mRNA or protein) is not
altered by DEX treatment; IL-5 mRNA levels are
modestly increased by DEX addition. These results
may indicate that the true effect of DEX on the
immune response is not to favor the humoral
response, but to induce the production of anti-
inflammatory cytokines (IL-4, IL- 10, and IL- 13). This
last idea harmonizes well with the physiology of
glucocorticoids, controlling the magnitude of the
protective responses of the body. Steroids will be
released by the adrenal glands during an immune
response when the mediators of inflammation reach
certain dangerous levels. These hormones have a
direct effect on the synthesis of these mediators of
inflammation but also may have some indirect and
long-lasting effect inducing the synthesis of anti-
inflammatory cytokines.
The data support the hypothesis outlined in the
Introduction that the autoregulation of EAE is
induced by endogenously produced glucocorticoids
(Mason, 1991). This hypothesis provides an explana-
tion for the recovery and refractory periods, but a
detailed analysis of the cytokines produced during the
different phases of EAE, and how endogenous
glucocorticoids affect this synthesis, is necessary to
demonstrate it. In other systems, a similar effect on240 E RAM[REZ
cytokine production induced by glucocorticoids has
been observed in vivo (Daynes and Araneo, 1989;
Daynes et al., 1990).
Our demonstration of the modulation of cytokine
gene expression by corticosteroids has a number of
more general implications. It may be anticipated that
endogenous production of these hormones in response
to environmental stress may interfere with the
immune response required to control infections that
normally elicit a protective Thl type reaction and
there are published data to support this suggestion
(Sheridan et al., 1991; Moynihan et al., 1994). Such
an interaction between the neuroendocrine system and
the immune system may, for example, help to explain
the prevalence of mycobacterial infections in areas of
poverty and malnutrition. Such a possibility has wide
implications for the control of such diseases. In
addition, our data provide an explanation for how
relatively short courses of high-dose steroids used
pharmacologically, for example, to control an episode
of renal allograft rejection, can apparently have
beneficial effects that persist after reduction of the
dose of the drug.
IL-4 was included in the experiments as a positive
control for the generation of a Th2 cytokine pattern in
vitro as already has been described (Swain et al.,
1990). As expected, we found very potent IL-4
production in the second stimulation and striking
inhibition of TNF and IL-2 synthesis in these
secondary cultures. However, we did not observe any
inhibition of IFN-y production in Con A-activated
cells (Figure 4). Increasing the amount of IL-4 in the
culture provokes inhibition of IFN-y production in the
secondary activation, but this inhibition was never
complete (data not shown). In contrast, a strong
inhibition of IFN-y production was observed in MLR-
activated cells, which indicates differences in the
activation signal between the two protocols.
In summary, the present work suggests that cortico-
steroids not only have a direct anti-inflammatory
effect (acute effect), but also promote a long-lasting
one, increasing the production of anti-inflammatory




Lewis, DA, and PVG.RT1 rats were from the specific
pathogen-free unit of the MRC Cellular Immunology
Unit (Oxford, UK).
Rat Recombinant Interleukins and Other
Reagents
Tissue-culture supernatants containing either rat rIL-2
or rat rlL-4 were obtained from stably transfected
CHO cell lines, using the rat IL-2 or rat IL-4 cDNA
sequences (McKnight and Classon, 1992). Rat rIFN-y
was kindly provided by P. van der Meide (Primate
Center TNO, Rijswijk, The Netherlands). Human rlL-
2 was from Boehringer Mannheim (Mannheim,
Germany). DEX (Sigma, USA) was stored as a stock
solution at 10-a M in ethanol and diluted into
complete medium just before its addition to culture.
Antibodies
Monoclonal antibodies used were W3/13 (anti-rat
CD43) (Williams et al., 1977); MRC-OX6 (anti-rat
MHC class II) (McMaster and Williams, 1979);
MRC-OX8 (anti-rat CD8) (Brideau et al., 1980);
MRC-OX12 (anti-rat t< chain) (Hunt and Fowler,
1981), MRC-OX39 (anti-rat IL-2Ro chain) (Paterson
et al., 1987), and MRC-OX81 (anti-rat IL-4) (Ramfrez
et al., 1996) were from the MRC Cellular Immuno-
logy Unit; DB-1 (mouse anti-rat IFN-y (Van der
Meide et al., 1986) was a generous gift of P. Van der
Meide (Primate Center TNO, Rijswijk, The Nether-
lands); polyclonal rabbit anti-mouse IFN-y was
kindly provided by J. Tite (Wellcome Research
Laboratories, Beckenham, UK); polyclonal rabbit
anti-rat TNF was from Innogenetics (Zwijndrecht,
Belgium).
Cells
Lymph node cells (LNC) were obtained from mesen-
teric and cervical LN. Spleen and LN were removed
aseptically from the rats and the cells were isolated byINDUCTION OF A TH2 RESPONSE BY GLUCOCORTICOIDS 241
pressing fragments of the tissue through a stainless
steel mesh into ice-cold PBS containing 0.2% BSA.
Rat thoracic duct lymphocytes (TDL) were obtained
by cannulation of the duct (Gowans and Knight,
1964).
Isolation of Subsets of Lymphocytes
Subpopulations of TDL, LNC, and splenocytes were
purified by negative selection using the rosetting
technique (Mason et al., 1987). CD4 T cells were
isolated by depletion of B cells, MHC class II cells,
CD8 T cells, and cells expressing IL-2R by using the
mAbs OX-12, OX-6, OX-8, and OX-39, respectively.
T-cell-depleted splenocytes, used as accessory cells in
Con A-activated cultures, were prepared by removal
of W3/13 positive cells. B cells were purified from
TDL by the rosetting technique using the mAb W3/
13. After all fractionation procedures cell purities
were assessed by labeling pre- and postdepletion
samples and analyzing on the FACScan flow cyto-
fluorograp (Becton-Dickinson, USA).
Cell Culture
To analyze long-lasting effects of GCs on Con A and
MLR activation, the protocol used is shown in Figure
1. CD4 T lymphocytes from LN or thoracic duct
were stimulated with Con A in the presence of
preirradiated T-cell-depleted splenocytes as accessory
cells (Con A activation) or irradiated allogenic
splenocytes (MLR activation) in RPMI culture
medium supplemented with FCS,/-ME, and antibiot-
ics. After 3 days in culture (primary activation), the
lymphocytes were cultured in the presence of 50 U/ml
of rat rIL-2 (expansion phase). Four days later, the
cells were centrifuged over a Ficoll-Hypaque density
gradient, washed and restimulated with Con A in the
presence of irradiated T-cell-depleted splenocytes
(secondary Con A activation) or irradiated allogenic
splenocytes (secondary MLR activation), and then
tested for cytokine production. As indicated in the text
and in Figure 1, some cultures were maintained in
different combinations ofDEX (10-SM) and rat rIL-4
(500 U/ml) during the primary activation or expan-
sion phase. In the remaining text of this paper, the
three phases of this protocol will be referred to as the
primary activation phase, the expansion phase, and
the secondary activation phase, respectively. For
determination of IL-4, IL-2, TNF, and IFN-y protein
production, supernatants were removed at 16 to 24 hr
after secondary activation and stored at -20C. RNA
extraction (see what follows) was performed after 11
to 24 hr of secondary activation.
RT-PCR Analysis of Lymphokine mRNA Levels
Total cellular RNA was extracted from 2 106
stimulated CD4 T cells with RNAzolTM B (Biotecx
Laboratories, Houston) according to the manufac-
turer’s instructions, using bacterial ribosomal RNA as
a carrier. RNA was reverse-transcribed using oligo-
dT as a primer and M-MLV reverse transcriptase
(Life Technologies, Paisley, Scotland). The cDNA
was serially diluted and IL-4 and /3-actin mRNAs
were amplified using the appropriate oligonucleotide
primers by PCR for 35 cycles (IL-4 mRNA) or 20
cycles (/3-actin mRNA) in a PTC-100 Programmable
Thermal Controller (MJ Research, Watertown, MA).
The reaction buffer and the primer sequences for rat
IL-4 and /3-actin have been previously described
(McKnight et al., 1991). These primers were designed
to amplify cDNA fragments of 378 bp for IL-4 and
607 bp for /3-actin. The amplified products were
visualized by ethidium bromide staining after agar-
ose-gel electrophoresis. In order to assure that the
PCR products were not being assayed on the plateau
of the amplification curve, all cDNA samples were
amplified at 3 tenfold dilutions. This procedure
allowed semiquantitative comparisons to be made of
the levels of cDNA present in different samples and
ensured that the /3-actin controls were also not run
under saturating (plateau) conditions.
Cytokine Assays
IFN-y was measured by a specific ELISA using the
mAb DB-1 (mouse anti-rat IFN-y) and a rabbit anti-
mouse IFN-y antiserum that cross-reacts with rat
IFN-y. Rat rIFN-y was used as a standard.242 F. RAM[REZ
IL-4 protein was measured in the supernatants from
activated rat CD4 T lymphocytes by the increase of
MHC class II expression on B cells. To assess the
specificity of the assay, the OX-81 mAb was included
in some incubations. One unit of IL-4 is defined as the
amount of IL-4 that promotes 50% of the maximal
class II induction on 5 105 B cells on a volume of
200/xl.
IL-2 production was measured using the mouse IL-
2-dependent cell line CTLL-2 (Gillis et al., 1978).
Human rIL-2 was used as a standard. The CTLL-2
cell line responds to rat IL-2 but not to rat rIL-4.
TNF production was measured using TNF-sensi-
tive actinomycin-D-treated murine L929 fibroblasts
(Aggarwal et al., 1984). To assess the specificity of
the assay, a polyclonal rabbit anti-rat TNF was used
and all the activity contained in the supernatants was
blocked.
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